Overall, these findings indicate that PURα promotes EMT and the transcriptional activation of the PCK2 gene in ESCC cells, while PCK2 can participate in the metabolic reprogramming of cancer cells. Here, PCK2 is linked to esophageal squamous cell carcinoma.